Mumbai-based e-pharmacy and telehealth platform Truemeds has secured $85 million in its Series C funding round, led by Accel and Peak XV Partners, with participation from WestBridge Capital and Info Edge Ventures. The round was completed in two tranches. The fresh capital will be used to open more fulfillment centers in high-demand non-metro areas, strengthen the company’s engineering and product teams with experienced talent, and set up a new office in Bengaluru to tap into India’s technology ecosystem. Truemeds also plans to triple its national reach and launch diagnostic services in the coming months.
Founded in 2019 by Akshat Nayyar and Dr Kunal Wani, Truemeds provides clinically equivalent alternatives to branded medicines, helping patients save 50–70% on monthly healthcare costs. The platform mainly serves chronic care patients dealing with conditions like diabetes, hypertension, and cardiovascular diseases. With this funding, Truemeds aims to make affordable, high-quality healthcare accessible to more people across India.
Also Read: How Jupiter Became a Fintech Giant in Just a Few Years
